                         SEQUENCE LISTING

<110>  Cornell University
 
<120>  INHIBITORS OF FUSION BETWEEN VIRAL AND CELL MEMBRANES AS WELL AS 
       COMPOSITIONS AND METHODS OF USING THEM

<130>  29543.7491 (6077-02-PC)

<150>  61/989,917
<151>  2014-05-07

<160>  38    

<170>  PatentIn version 3.5

<210>  1
<211>  42
<212>  PRT
<213>  Artificial

<220>
<223>  Measles Virus HRC1 peptide derived from C-terminal heptad repeat 
       region

<400>  1

Pro Pro Ile Ser Leu Glu Arg Leu Asp Val Gly Thr Asn Leu Gly Asn 
1               5                   10                  15      


Ala Ile Ala Lys Leu Glu Asp Ala Lys Glu Leu Leu Glu Ser Ser Asp 
            20                  25                  30          


Gln Ile Leu Arg Gly Ser Gly Ser Gly Cys 
        35                  40          


<210>  2
<211>  11
<212>  PRT
<213>  Artificial

<220>
<223>  HIV-1 Tat Peptide

<400>  2

Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10      


<210>  3
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  C105Y peptide

<400>  3

Pro Phe Val Tyr Leu Ile 
1               5       


<210>  4
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VG peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is NH2

<400>  4

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly 
            20                  25                  30          


Lys Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  5
<211>  43
<212>  PRT
<213>  Artificial

<220>
<223>  VG-chol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  X at position 43 is (chol)-NH2

<400>  5

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly 
            20                  25                  30          


Lys Leu Asp Ser Ile Gly Ser Gly Ser Cys Xaa 
        35                  40              


<210>  6
<211>  43
<212>  PRT
<213>  Artificial

<220>
<223>  VG-PEG4-chol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  X at position 43 is (PEG4-chol)-NH2

<400>  6

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly 
            20                  25                  30          


Lys Leu Asp Ser Ile Gly Ser Gly Ser Cys Xaa 
        35                  40              


<210>  7
<211>  43
<212>  PRT
<213>  Artificial

<220>
<223>  VG-PEG24-chol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  X at position 43 is (PEG24-chol)-NH2

<400>  7

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly 
            20                  25                  30          


Lys Leu Asp Ser Ile Gly Ser Gly Ser Cys Xaa 
        35                  40              


<210>  8
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-chol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-chol)-NH2

<400>  8

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  9
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-toc peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-toc)-NH2

<400>  9

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  10
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-palm peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-palm)-NH2

<400>  10

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  11
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-25OHchol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-25OHchol)-NH2

<400>  11

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  12
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-C20 peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-C20)-NH2

<400>  12

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  13
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-C30 peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-C30)-NH2

<400>  13

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  14
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-Betulinic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-Betulinic)-NH2

<400>  14

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  15
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG4-Ursolic peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG4-Ursolic)-NH2

<400>  15

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  16
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG24-chol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG24-chol)-NH2

<400>  16

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  17
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIKI-PEG24-toc peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG24-toc)-NH2

<400>  17

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  18
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIQKI-PEG24-chol peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG24-chol)-NH2

<400>  18

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Gln Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  19
<211>  44
<212>  PRT
<213>  Artificial

<220>
<223>  VIQKI-PEG24-toc peptide


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (44)..(44)
<223>  X at position 44 is (PEG24-toc)-NH2

<400>  19

Xaa Val Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ile 
1               5                   10                  15      


Lys Ser Gln Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Lys 
            20                  25                  30          


Ile Leu Asp Ser Ile Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  


<210>  20
<211>  32
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor EBOLA


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (32)..(32)
<223>  X at position 32 is NH2

<400>  20

Xaa Ile Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp 
1               5                   10                  15      


Gln Ile Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Cys Xaa 
            20                  25                  30          


<210>  21
<211>  31
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor EBOLA-dPEG4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  X at position 31 is dPEG4-C-NH2

<400>  21

Xaa Ile Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp 
1               5                   10                  15      


Gln Ile Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Xaa 
            20                  25                  30      


<210>  22
<211>  31
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor EBOLA-dPEG4-Chol


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  X at position 31 is dPEG4-C-(Cholesterol)

<400>  22

Xaa Ile Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp 
1               5                   10                  15      


Gln Ile Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Xaa 
            20                  25                  30      


<210>  23
<211>  31
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor EBOLA-dPEG4-Toc


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (31)..(31)
<223>  X at position 31 is dPEG4-C-(Tocopherol)

<400>  23

Xaa Ile Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp 
1               5                   10                  15      


Gln Ile Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Xaa 
            20                  25                  30      


<210>  24
<211>  46
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-EBOLA


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (46)..(46)
<223>  X at position 46 is NH2

<400>  24

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Ile 
1               5                   10                  15      


Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile 
            20                  25                  30          


Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Cys Xaa 
        35                  40                  45      


<210>  25
<211>  45
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-EBOLA-dPEG4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  X at position 45 is dPEG4-C-NH2

<400>  25

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Ile 
1               5                   10                  15      


Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile 
            20                  25                  30          


Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Xaa 
        35                  40                  45  


<210>  26
<211>  45
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-EBOLA-dPEG4-Chol


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  X at position 45 is dPEG4-C-(Cholesterol)

<400>  26

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Ile 
1               5                   10                  15      


Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile 
            20                  25                  30          


Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Xaa 
        35                  40                  45  


<210>  27
<211>  45
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-EBOLA-dPEG4-Toc


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (45)..(45)
<223>  X at position 45 is dPEG4-C-(Tocopherol)

<400>  27

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Ile 
1               5                   10                  15      


Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile 
            20                  25                  30          


Ile His Asp Phe Val Asp Lys Gly Ser Gly Ser Gly Xaa 
        35                  40                  45  


<210>  28
<211>  52
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-HPIV3-dPEG4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (52)..(52)
<223>  X at position 52 is dPEG4-C-NH2

<400>  28

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Val 
1               5                   10                  15      


Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala Lys Ser 
            20                  25                  30          


Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly Lys Leu 
        35                  40                  45              


Asp Ser Ile Xaa 
    50          


<210>  29
<211>  52
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-HPIV3-dPEG4-Chol


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (52)..(52)
<223>  X at position 52 is dPEG4-C-(Cholesterol)

<400>  29

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Val 
1               5                   10                  15      


Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala Lys Ser 
            20                  25                  30          


Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly Lys Leu 
        35                  40                  45              


Asp Ser Ile Xaa 
    50          


<210>  30
<211>  52
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor TAT-HPIV3-dPEG4-Toc


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (52)..(52)
<223>  X at position 52 is dPEG4-C-(Tocopherol)

<400>  30

Xaa Tyr Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Gly Ser Gly Val 
1               5                   10                  15      


Ala Leu Asp Pro Ile Asp Ile Ser Ile Val Leu Asn Lys Ala Lys Ser 
            20                  25                  30          


Asp Leu Glu Glu Ser Lys Glu Trp Ile Arg Arg Ser Asn Gly Lys Leu 
        35                  40                  45              


Asp Ser Ile Xaa 
    50          


<210>  31
<211>  40
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor C105-EBOLA-dPEG4


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  X at position 40 is dPEG4-C-NH2

<400>  31

Xaa Pro Phe Val Tyr Leu Ile Gly Ser Gly Ile Glu Pro His Asp Trp 
1               5                   10                  15      


Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile Ile His Asp Phe Val 
            20                  25                  30          


Asp Lys Gly Ser Gly Ser Gly Xaa 
        35                  40  


<210>  32
<211>  40
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor  C105-EBOLA-dPEG4-Chol


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  X at position 40 is dPEG4-C-(Cholesterol)

<400>  32

Xaa Pro Phe Val Tyr Leu Ile Gly Ser Gly Ile Glu Pro His Asp Trp 
1               5                   10                  15      


Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile Ile His Asp Phe Val 
            20                  25                  30          


Asp Lys Gly Ser Gly Ser Gly Xaa 
        35                  40  


<210>  33
<211>  40
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor C105-EBOLA-dPEG4-Toc


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (40)..(40)
<223>  X at position 40 is dPEG4-C-(Tocopherol)

<400>  33

Xaa Pro Phe Val Tyr Leu Ile Gly Ser Gly Ile Glu Pro His Asp Trp 
1               5                   10                  15      


Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln Ile Ile His Asp Phe Val 
            20                  25                  30          


Asp Lys Gly Ser Gly Ser Gly Xaa 
        35                  40  


<210>  34
<211>  43
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor FIV-dPEG4-Chol


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  X at position 43 is dPEG4-C-(Cholesterol)

<400>  34

Xaa Trp Tyr Asn Gln Thr Lys Asp Leu Gln Gln Lys Phe Tyr Glu Ile 
1               5                   10                  15      


Ile Met Asp Ile Ile Glu Gln Asn Asn Val Gln Gly Lys Lys Gly Ile 
            20                  25                  30          


Gln Gln Leu Gln Lys Gly Ser Gly Ser Gly Xaa 
        35                  40              


<210>  35
<211>  43
<212>  PRT
<213>  Artificial

<220>
<223>  Viral peptide inhibitor FIV-dPEG4-Toc


<220>
<221>  MISC_FEATURE
<222>  (1)..(1)
<223>  X at position 1 is an acetyl group

<220>
<221>  MISC_FEATURE
<222>  (43)..(43)
<223>  X at position 43 is dPEG4-C-(Tocopherol)

<400>  35

Xaa Trp Tyr Asn Gln Thr Lys Asp Leu Gln Gln Lys Phe Tyr Glu Ile 
1               5                   10                  15      


Ile Met Asp Ile Ile Glu Gln Asn Asn Val Gln Gly Lys Lys Gly Ile 
            20                  25                  30          


Gln Gln Leu Gln Lys Gly Ser Gly Ser Gly Xaa 
        35                  40              


<210>  36
<211>  24
<212>  PRT
<213>  Artificial

<220>
<223>  C-terminal heptad repeat region of Zaire Ebola GP2 610-633

<400>  36

Ile Glu Pro His Asp Trp Thr Lys Asn Ile Thr Asp Lys Ile Asp Gln 
1               5                   10                  15      


Ile Ile His Asp Phe Val Asp Lys 
            20                  


<210>  37
<211>  24
<212>  PRT
<213>  Artificial

<220>
<223>  C-terminal heptad repeat region of Marburg Lake Victoria-Musoke

<400>  37

Ile Gly Ile Glu Asp Leu Ser Lys Asn Ile Ser Glu Gln Ile Asp Gln 
1               5                   10                  15      


Ile Lys Lys Asp Glu Gln Lys Glu 
            20                  


<210>  38
<211>  36
<212>  PRT
<213>  Artificial

<220>
<223>  Measles Virus HRC1 peptide derived from C-terminal heptad repeat 
       region

<400>  38

Pro Pro Ile Ser Leu Glu Arg Leu Asp Val Gly Thr Asn Leu Gly Asn 
1               5                   10                  15      


Ala Ile Ala Lys Leu Glu Asp Ala Lys Glu Leu Leu Glu Ser Ser Asp 
            20                  25                  30          


Gln Ile Leu Arg 
        35      


